Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn

被引:105
作者
Carey, A. N.
Borozny, K.
Aldrich, J. V.
McLaughlin, J. P.
机构
[1] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA
[2] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
关键词
cocaine; reward; reinstatement; arodyn; kappa opioid antagonist;
D O I
10.1016/j.ejphar.2007.05.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Stress contributes to the reinstatement of cocaine-seeking behavior in abstinent subjects. Kappa-opioid receptor antagonists attenuate the behavioral effects of stress, potentially providing therapeutic value in treating cocaine abuse, Presently, the peptide arodyn produced long-lasting kappa-opioid receptor antagonism, suppressing kappa-opioid receptor agonist-induced antinociception at least 3 days after intracerebroventricular administration of 0.3 nmol. C57B1/6J mice demonstrated cocaine-conditioned place preference, extinction over 3 weeks, and a subsequent reinstatement of place preference. Arodyn pretreatment suppressed stress-induced, but not cocaine-exposed, reinstatement of cocaine place preference. These results verify that arodyn and other kappa-opioid receptor antagonists may be useful therapeutics for cocaine abuse. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:84 / 89
页数:6
相关论文
共 36 条
[1]   CONDITIONED PLACE PREFERENCE USING OPIATE AND STIMULANT-DRUGS - A METAANALYSIS [J].
BARDO, MT ;
ROWLETT, JK ;
HARRIS, MJ .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1995, 19 (01) :39-51
[2]   Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats [J].
Beardsley, PM ;
Howard, JL ;
Shelton, KL ;
Carroll, FI .
PSYCHOPHARMACOLOGY, 2005, 183 (01) :118-126
[3]   Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist [J].
Bennett, MA ;
Murray, TF ;
Aldrich, JV .
JOURNAL OF PEPTIDE RESEARCH, 2005, 65 (03) :322-332
[4]   Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a κ opioid receptor antagonist [J].
Bennett, MA ;
Murray, TF ;
Aldrich, JV .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (26) :5617-5619
[5]  
Bilsky EJ, 1996, J PHARMACOL EXP THER, V277, P484
[6]   Influence of the dose and the number of drug-context pairings on the magnitude and the long-lasting retention of cocaine-induced conditioned place preference in C57BL/6J mice [J].
Brabant, C ;
Quertemont, E ;
Tirelli, E .
PSYCHOPHARMACOLOGY, 2005, 180 (01) :33-40
[7]  
Brugos B, 2004, AAPS J, V6
[8]   Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys [J].
Butelman, ER ;
Vivian, JA ;
Yu, J ;
Kreek, MJ ;
Woods, JH .
PSYCHOPHARMACOLOGY, 1999, 143 (02) :190-196
[9]   Pharmacotherapies for treatment of cocaine abuse: Preclinical aspects [J].
Carroll, FI ;
Howell, LL ;
Kuhar, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) :2721-2736
[10]   Pharmacological properties of JDTic:: a novel κ-opioid receptor antagonist [J].
Carroll, I ;
Thomas, JB ;
Dykstra, LA ;
Granger, AL ;
Allen, RM ;
Howard, JL ;
Pollard, GT ;
Aceto, MD ;
Harris, LS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 501 (1-3) :111-119